Developer docs
API playgroundTry for free, no card

Search company profiles

Innovation Fund

Full company profile

uuid000aam8

Namestring
Innovation Fund
Legal namestring
Innovation Fund sa/nv
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBrussels, Belgium
HQ citystring
Brussels
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital funding, early stage investment, chemistry sector investing, life sciences investment, seed financing
Industry3 codes
1FSANAJAN
CodeFSANAJANPrimaryYes
2FSANAJAA
CodeFSANAJAAPrimaryNo
3BPADACAO
CodeBPADACAOPrimaryNo
NAICS code2 codes
  • 5259
  • 525
SIC code2 codes
  • 6282
  • 8742
Product category
Venture Capital
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Capital Gains from Investment Exits
TypeTransaction Fee
Description

The fund generates returns through successful exits of portfolio companies via acquisitions, IPOs, or secondary sales. Notable exits include PharmaFluidics (sold to Thermo Fisher Scientific), TrendMiner (sold to Software AG), Aerosint (sold to Desktop Metal), and others. The evergreen structure allows the fund to continuously realize gains and reinvest.

innovationfund.eu
2Management Fees and Co-investment Returns
TypeSubscription Recurring
Description

The fund charges management fees and participates in co-investments alongside syndicate partners including Gemma Frisius, PMV, SOFI, Qbic, Noshaq, and various business angels. Returns flow back to investors including major industrial companies (Total, Solvay, BASF, Carmeuse, Recticel, Sioen, Soudal, etc.).

innovationfund.eu
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Innovation Fund is a Belgian venture capital fund that provides seed and early-stage equity financing to startups and SMEs active in chemistry and life sciences. Founded in 2015 with initial capital of 13 million EUR (increased to 35 million EUR in October 2019), the fund invests EUR 30,000 to EUR 4 million per company across five segments including circular economy, biosciences, nanomaterials, 3D printing/additive manufacturing, and medical devices. It operates an evergreen structure with 20-30 active participations, offering portfolio companies not only capital but also industry mentorship through the Innovation Circle and access to the networks of its major chemical industry investors.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Innovation Fund is a Belgian venture capital fund that invests in innovative startups and companies active in the field of chemistry and life sciences. Founded in February 2015 with initial capital of 13 million EUR, it has grown to 35 million EUR after a capital increase in October 2019. The fund operates with an evergreen structure, targeting 20-30 participations at any time, focusing on seed and early-stage financing primarily in Belgium. The fund's portfolio spans multiple sectors including circular economy, materials technology, biosciences, industrial processes, medical devices, and digital health solutions. The fund does not offer a product or service itself; rather it provides capital and strategic support to portfolio companies developing technologies in areas such as wastewater treatment (InOpSys), EHS software (Lisam/ExeSS), liquid chromatography (PharmaFluidics), industrial analytics (TrendMiner), 3D printing (Aerosint, Spentys), smartglasses (Iristick), water treatment membranes (Blue Foot Membranes), and various biotech innovations.

Product and service3 records
1Seed and Early-Stage Equity Financing
CategoryVenture Capital Financing
2Innovation Circle Mentorship Program
CategoryMentorship and Advisory Services
3essenscia Innovation Award Contest
CategoryIndustry Award and Deal Sourcing
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Belgium's federation for chemistry and life sciences, which created the Innovation Fund alongside François Cornelis and hosts the fund at its offices in Schaerbeek. Yves Verschueren serves as General Secretary of the fund and represents essenscia on the Board.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Permanent structure created in 2013 by François Cornelis offering startups and SMEs free assistance and mentoring. Gathers 13 ex-CEOs and academics of the chemical sector including Christian Jourquin and Carl Van Camp who serve on the Investment Committee.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Major Belgian university and founding academic partner. Ilse Sienaert represents KU Leuven on the Board, Kurt De Smet serves on the Investment Committee. Source of multiple spin-offs including PharmaFluidics, InOpSys, and Zeopore Technologies.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Belgian VC fund manager focused on early-stage technology investments in chemistry, materials, and life sciences. Capricorn's Chemistry and Sustainable Chemistry funds are directly comparable to the Innovation Fund's mandate of backing Belgian and European chemistry startups with industrial LP backing.

TypeDirect peer
Description

Flemish regional investment company co-investing alongside the Innovation Fund in multiple deals (InOpSys, etc.). PMV is one of the fund's closest syndicate partners and serves a comparable role providing risk capital to Flemish technology and life sciences companies.

TypeDirect peer
Description

KU Leuven's seed and early-stage investment fund that has co-invested with the Innovation Fund in InOpSys, Zeopore Technologies, and REIN4CED. Both funds serve a similar role bridging Belgian university spin-outs to commercial capital.

TypeDirect peer
Description

Belgian VC firm and recurring syndicate partner of the Innovation Fund (Aerosint, Graftys, LiveDrop). Noshaq invests in early-stage tech and life sciences companies in Belgium's Wallonia region, overlapping significantly in deal universe.

TypeBroad incumbent
Description

Belgian investment holding company with significant exposure to European growth-stage technology and life sciences. Sofina operates as a broader incumbent in the Belgian VC ecosystem, with much larger AUM than the Innovation Fund and comparable thematic focus on chemistry-adjacent sectors.

TypeDirect peer
Description

Belgian inter-university seed and early-stage fund focused on tech and life sciences spin-outs. Qbic has co-invested with the Innovation Fund (Blue Foot Membranes, Aloxy) and serves the same niche market of Belgian academic startups.

TypeDirect peer
Description

Walloon regional investment company that became an LP in the Innovation Fund (October 2019) and has co-invested directly (PurVer). SRIW plays a comparable role in the Walloon venture ecosystem, backing chemistry and environmental startups.

TypeDirect peer
Description

Belgian VC fund that has co-invested with the Innovation Fund in AllerInvest, Univercells, and Fluigent. Inventures operates in the same Belgian early-stage tech and life sciences niche.

TypeDirect peer
Description

Belgian early-stage VC co-investing with the Innovation Fund in AllerInvest, TheraVet, and Apaxen. Theodorus targets Belgian academic spin-outs in life sciences and digital health with a similar cheque-size profile.

TypeRegional player
Description

Belgian deep-tech VC fund affiliated with imec, focused on semiconductor and nanotechnology spin-outs. While not chemistry-focused, imec.xpand operates in the same Belgian deep-tech innovation ecosystem and shares Belgian university sourcing channels with the Innovation Fund.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment30 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Innovation Fund

Venture Capitalinnovationfund.eu

Innovation Fund firmographics

Firmographics
Name
Innovation Fund
Legal name
Innovation Fund sa/nv
Website
https://innovationfund.eu
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where Innovation Fund is headquartered

Location

Headquarters

HQ city
Brussels
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Innovation Fund business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Capital Gains from Investment Exits: The fund generates returns through successful exits of portfolio companies via acquisitions, IPOs, or secondary sales. Notable exits include PharmaFluidics (sold to Thermo Fisher Scientific), TrendMiner (sold to Software AG), Aerosint (sold to Desktop Metal), and others. The evergreen structure allows the fund to continuously realize gains and reinvest.
  2. Management Fees and Co-investment Returns: The fund charges management fees and participates in co-investments alongside syndicate partners including Gemma Frisius, PMV, SOFI, Qbic, Noshaq, and various business angels. Returns flow back to investors including major industrial companies (Total, Solvay, BASF, Carmeuse, Recticel, Sioen, Soudal, etc.).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Innovation Fund product offering

Product offering

Core offering

The Innovation Fund is a Belgian venture capital fund that provides seed and early-stage equity financing to startups and SMEs active in chemistry and life sciences. Founded in 2015 with initial capital of 13 million EUR (increased to 35 million EUR in October 2019), the fund invests EUR 30,000 to EUR 4 million per company across five segments including circular economy, biosciences, nanomaterials, 3D printing/additive manufacturing, and medical devices. It operates an evergreen structure with 20-30 active participations, offering portfolio companies not only capital but also industry mentorship through the Innovation Circle and access to the networks of its major chemical industry investors.

Product overview

Innovation Fund is a Belgian venture capital fund that invests in innovative startups and companies active in the field of chemistry and life sciences. Founded in February 2015 with initial capital of 13 million EUR, it has grown to 35 million EUR after a capital increase in October 2019. The fund operates with an evergreen structure, targeting 20-30 participations at any time, focusing on seed and early-stage financing primarily in Belgium. The fund's portfolio spans multiple sectors including circular economy, materials technology, biosciences, industrial processes, medical devices, and digital health solutions. The fund does not offer a product or service itself; rather it provides capital and strategic support to portfolio companies developing technologies in areas such as wastewater treatment (InOpSys), EHS software (Lisam/ExeSS), liquid chromatography (PharmaFluidics), industrial analytics (TrendMiner), 3D printing (Aerosint, Spentys), smartglasses (Iristick), water treatment membranes (Blue Foot Membranes), and various biotech innovations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Seed and Early-Stage Equity Financing
  • Innovation Circle Mentorship Program
  • essenscia Innovation Award Contest

Companies that use Innovation Fund

Customer profile

Segments1 record

Ideal customer profiles1 record

Innovation Fund technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Innovation Fund partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and major.

  • essensciacoreStrategic or Co-development PartnerBelgium's federation for chemistry and life sciences, which created the Innovation Fund alongside François Cornelis and hosts the fund at its offices in Schaerbeek. Yves Verschueren serves as General Secretary of the fund and represents essenscia on the Board.
  • Innovation CirclecoreStrategic or Co-development PartnerPermanent structure created in 2013 by François Cornelis offering startups and SMEs free assistance and mentoring. Gathers 13 ex-CEOs and academics of the chemical sector including Christian Jourquin and Carl Van Camp who serve on the Investment Committee.
  • KU LeuvenmajorStrategic or Co-development PartnerMajor Belgian university and founding academic partner. Ilse Sienaert represents KU Leuven on the Board, Kurt De Smet serves on the Investment Committee. Source of multiple spin-offs including PharmaFluidics, InOpSys, and Zeopore Technologies.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Innovation Fund competitors and assessment

Company assessment

Direct peers

  • Capricorn Partners: Belgian VC fund manager focused on early-stage technology investments in chemistry, materials, and life sciences. Capricorn's Chemistry and Sustainable Chemistry funds are directly comparable to the Innovation Fund's mandate of backing Belgian and European chemistry startups with industrial LP backing.
  • PMV (Participatiemaatschappij Vlaanderen): Flemish regional investment company co-investing alongside the Innovation Fund in multiple deals (InOpSys, etc.). PMV is one of the fund's closest syndicate partners and serves a comparable role providing risk capital to Flemish technology and life sciences companies.
  • Gemma Frisius Fund: KU Leuven's seed and early-stage investment fund that has co-invested with the Innovation Fund in InOpSys, Zeopore Technologies, and REIN4CED. Both funds serve a similar role bridging Belgian university spin-outs to commercial capital.
  • Noshaq: Belgian VC firm and recurring syndicate partner of the Innovation Fund (Aerosint, Graftys, LiveDrop). Noshaq invests in early-stage tech and life sciences companies in Belgium's Wallonia region, overlapping significantly in deal universe.
  • Qbic (Interuniversitair Micro-Electronica Centrum fund): Belgian inter-university seed and early-stage fund focused on tech and life sciences spin-outs. Qbic has co-invested with the Innovation Fund (Blue Foot Membranes, Aloxy) and serves the same niche market of Belgian academic startups.
  • S.R.I.W. (Société Régionale d'Investissement de Wallonie): Walloon regional investment company that became an LP in the Innovation Fund (October 2019) and has co-invested directly (PurVer). SRIW plays a comparable role in the Walloon venture ecosystem, backing chemistry and environmental startups.
  • Investventures (Inventures): Belgian VC fund that has co-invested with the Innovation Fund in AllerInvest, Univercells, and Fluigent. Inventures operates in the same Belgian early-stage tech and life sciences niche.
  • Theodorus Fund: Belgian early-stage VC co-investing with the Innovation Fund in AllerInvest, TheraVet, and Apaxen. Theodorus targets Belgian academic spin-outs in life sciences and digital health with a similar cheque-size profile.

Broad incumbents

  • Sofina: Belgian investment holding company with significant exposure to European growth-stage technology and life sciences. Sofina operates as a broader incumbent in the Belgian VC ecosystem, with much larger AUM than the Innovation Fund and comparable thematic focus on chemistry-adjacent sectors.

Regional players

  • imec.xpand: Belgian deep-tech VC fund affiliated with imec, focused on semiconductor and nanotechnology spin-outs. While not chemistry-focused, imec.xpand operates in the same Belgian deep-tech innovation ecosystem and shares Belgian university sourcing channels with the Innovation Fund.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Innovation Fund social profiles

Digital presence

Innovation Fund financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Innovation Fund leadership team

Management profile

Number of profiles

Profiles4 records

Innovation Fund funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Innovation Fund M&A and investment

M&A and investment

M&A

Investments30 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovation Fund

What does Innovation Fund do?

The Innovation Fund is a Belgian venture capital fund that provides seed and early-stage equity financing to startups and SMEs active in chemistry and life sciences. Founded in 2015 with initial capital of 13 million EUR (increased to 35 million EUR in October 2019), the fund invests EUR 30,000 to EUR 4 million per company across five segments including circular economy, biosciences, nanomaterials, 3D printing/additive manufacturing, and medical devices. It operates an evergreen structure with 20-30 active participations, offering portfolio companies not only capital but also industry mentorship through the Innovation Circle and access to the networks of its major chemical industry investors.

Is Innovation Fund a public or private company?

Innovation Fund is a private company. It is classified as corporate owned and is currently operating.

When was Innovation Fund founded?

Innovation Fund was founded in 2015. It employs 1 to 10 people.

Where is Innovation Fund based?

Innovation Fund is headquartered in Brussels, Belgium, in the Europe region.

How does Innovation Fund make money?

Two revenue lines are on record. Capital Gains from Investment Exits are the primary driver. The others are management Fees and Co-investment Returns.

Who are Innovation Fund's main competitors?

Direct peers on record are Capricorn Partners, PMV (Participatiemaatschappij Vlaanderen), Gemma Frisius Fund, Noshaq, Qbic (Interuniversitair Micro-Electronica Centrum fund), S.R.I.W. (Société Régionale d'Investissement de Wallonie), Investventures (Inventures) and Theodorus Fund. Sofina is listed as a broad incumbent. imec.xpand is listed as a regional player.

Does Innovation Fund have an API?

No public API is recorded for Innovation Fund.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FuelcellsworksGreenH Receives EU Funding for Hydrogen HubGreenH has been awarded approximately NOK 600 million in support from the EU's Innovation Fund for developing a hydrogen hub in Rogaland, Norway, with operations targeted to begin around 2030. The planned facility will have an electrolysis capacity of 12.5 MW, producing around five tonnes of green hydrogen per day for maritime transport, local industry, and heavy transport. The project is part of GreenH's broader effort to build nationwide hydrogen infrastructure along the Norwegian coast, including facilities in Slagentangen, Kristiansund, Sandnessjøen, Bodø, and Hammerfest.ReedsmithDecarbonizing Aviation: When European Law Becomes a Financing EngineThe European Union has established a comprehensive regulatory and financial ecosystem to accelerate the decarbonization of aviation through mechanisms like the EU ETS, ReFuelEU, and the Taxonomy framework. These policies aim to mobilize long-term capital by combining carbon pricing, transparency requirements such as CSRD, and public funding from institutions like the EIB and Innovation Fund to de-risk green projects. This approach seeks to reduce the cost of capital for aligned initiatives and drive the industrial scale-up of sustainable aviation fuels and new propulsion technologies.CleantechforeuropeCleantech for Europe‘s Policy Update - June EditionThe European Commission unveiled a Startup and Scaleup Strategy aimed at boosting innovative businesses through funding commitments, regulatory harmonization, and new financial instruments like the Scaleup Europe Fund. Concurrently, the Commission released a Single Market Strategy alongside an Omnibus package to reduce trade barriers, simplify regulations for SMEs, and streamline renewable energy permitting. These policy updates are complemented by significant funding allocations from the European Hydrogen Bank and Innovation Fund, as well as private sector investments in clean tech infrastructure.PR NewswireVolvo Group Receives EU Innovation Support for CarbonSmart InitiativeVolvo Group's engine plant in Skövde, Sweden has been awarded up to €49 million from the EU Innovation Fund to support the CarbonSmart Factory project (SPACE), aimed at transforming the facility through net-zero innovation and clean technology. The initiative targets an 88% reduction in CO₂ emissions from manufacturing processes by electrifying key operations, integrating AI-powered energy management, replacing propane with hydrogen, and deploying advanced heat recovery systems. The project will also implement three innovative energy storage solutions—iron, hydrogen, and water batteries—to balance energy use and address grid capacity limitations.European UnionPublic funding for permanent carbon removal in the EUAn event in the EU will explore financing landscapes for climate action, specifically focusing on instruments supporting permanent carbon removal. Participants will examine existing European funding mechanisms like the Innovation Fund and Horizon Europe to debate improvements. The initiative aims to foster stakeholder dialogue and provide actionable insights for effective financial support of climate goals.Bretagne-economiquePloemeur (56). La startup SENSE in® lève 1,55 millions d’euros pour se déployer à échelle industrielleMorbihan-based startup SENSE in, which designs data sensors for composite materials, has raised 1.55 million euros from Go Capital, Innovation Fund, SFLD and Crédit Agricole Morbihan Expansion. The funding aims to accelerate development of its composite equipment health monitoring solution and prepare for industrial-scale manufacturing.